✦ LIBER ✦

Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies

✍ Scribed by Elewski, Boni E.; Rich, Phoebe; Pollak, Richard; Pariser, David M.; Watanabe, Shinichi; Senda, Hisato; Ieda, Chikara; Smith, Kathleen; Pillai, Radhakrishnan; Ramakrishna, Tage; Olin, Jason T.

Book ID: 118275963
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 886 KB
Volume: 68
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2012.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transdermal buprenorphine in the treatme

Transdermal buprenorphine in the treatment of chronic pain: Resultsof a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Jürgen Sorge; Reinhard Sittl 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 935 KB

Efficacy of spraying l-menthol solution

Efficacy of spraying l-menthol solution during endoscopic treatment of early gastric cancer: a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Mitsuhiro Fujishiro, Michio Kaminishi, Naoki Hiki… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 340 KB

Efficacy of Dysport® (Botulinum toxin ty

Efficacy of Dysport® (Botulinum toxin type A) for the treatment of cervical dystonia: A multicenter, randomized, double-blind, placebo-controlled phase III study

✍ Truong Daniel; Lew Mark; Orlova Olga 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Two phase III, multicenter, double-blind

Two phase III, multicenter, double-blind, randomized, placebo-controlled trials evaluating the efficacy and safety of autologous fibroblast therapy in the treatment of nasolabial fold wrinkles

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Two phase III, multicenter, double-blind

Two phase III, multicenter, double-blind, randomized, placebo-controlled trials evaluating the efficacy and safety of autologous fibroblast therapy in the treatment of nasolabial fold wrinkles

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Results of a multicenter, randomized, do

Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

✍ John Glaspy; Michael B. Atkins; Jon M. Richards; Sanjiv S. Agarwala; Steven O'Da 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views